tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Madrigal Pharmaceuticals price target raised to $590 from $500 at Oppenheimer
PremiumThe FlyMadrigal Pharmaceuticals price target raised to $590 from $500 at Oppenheimer
6d ago
Akero Therapeutics downgraded to Hold from Buy at Clear Street
Premium
The Fly
Akero Therapeutics downgraded to Hold from Buy at Clear Street
7d ago
Midday Fly By: Delta beats, PepsiCo names new CFO
Premium
The Fly
Midday Fly By: Delta beats, PepsiCo names new CFO
7d ago
Akero Therapeutics jumps 18% to $54.74 after Novo Nordisk buyout offer
PremiumThe FlyAkero Therapeutics jumps 18% to $54.74 after Novo Nordisk buyout offer
7d ago
Akero Therapeutics to be acquired by Novo Nordisk for up to $5.2B in cash
Premium
The Fly
Akero Therapeutics to be acquired by Novo Nordisk for up to $5.2B in cash
7d ago
Akero Therapeutics to be acquired by Novo Nordisk for up to $5.2B in cash
Premium
The Fly
Akero Therapeutics to be acquired by Novo Nordisk for up to $5.2B in cash
7d ago
Novo Nordisk upgraded to Buy from Hold at HSBC
PremiumThe FlyNovo Nordisk upgraded to Buy from Hold at HSBC
15d ago
Moderately bullish activity in Novo Nordisk with shares down 1.23%
Premium
The Fly
Moderately bullish activity in Novo Nordisk with shares down 1.23%
16d ago
LifeMD offers Ozempic at $499 per month via Novo Nordisk collaboration
Premium
The Fly
LifeMD offers Ozempic at $499 per month via Novo Nordisk collaboration
16d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100